Johnson Matthey appoints Nicholas Shackley

Johnson Matthey (JM), working to provide cleaner air, improved health and more efficient use of natural resources, is pleased to announce the appointment of Nicholas Shackley to the role of Global VP Innovator of Products and Solutions.

In this role Shackley will lead JM custom development and manufacturing offering to pharmaceutical and biotechnology customers who are developing novel therapies and innovative medication.

This offering includes a broad range of enabling technologies and extensive global facilities including R&D centres located in Devens, Massachusetts and Cambridge, UK as well as manufacturing sites in West Deptford, New Jersey; Conshohocken, Philadelphia; North Andover, Massachusetts; and Annan, Scotland.

In addition to the existing offer, Nicholas will be responsible for growing the capabilities through addition of new technologies and assets to service the expanding market for technology-enabled custom development and manufacturing solutions.

Shackley brings a wealth of experience to JM, having most recently held the position of Senior VP at Aceto Corporation where he was responsible for the pharmaceutical ingredients businesses. Prior to this he has had senior positions at BASF, Cambrex and Avecia and holds a BEng from Imperial College, London.

“We are excited to have Nicholas join our Health Sector in this critical position,” said Robert MacLeod, Chief Executive of JM.

“His extensive knowledge of the pharmaceutical innovator market coupled with his senior leadership skills will be invaluable in driving our strategic growth-providing solutions to the clinical development and commercial manufacturing needs of the pharma and biotech industries.”

You may also like